Literature DB >> 31970785

Brazilian consensus on the diagnosis and treatment of extremities soft tissue sarcomas.

Ranyell M S S B Spencer1, Veridiana P de Camargo2, Maria L G Silva3, Fabio F E Pinto4, Felipe D'Almeida Costa5, Wagner S Cequeira6, Rodrigo R Munhoz2, Celso A Mello2, Rafael A Schmerling2, Waldec J D Filho2, Tharcisio M Coelho3, Alexandre V A Ambrosio3, Elton T T Leite3, Samir A Hanna3, Sueli A Nakagawa4, Andre M Baptista4, Rodrigo N Pinheiro1, Jadivan L de Oliveira1, Marcelo Sá de Araújo1, Raphael L C de Araujo1, Gustavo A Laporte1, Claudio de Almeida Quadros1, Alexandre F de Oliveira1, Ademar Lopes1.   

Abstract

INTRODUCTION: Soft tissue sarcomas (STSs) are rare tumors and constitute only 1% of all tumors in adults. Indeed, due to their rarity, most cases in Brazil are not treated according to primary international guidelines.
METHODS: This consensus addresses the treatment of STSs in the extremities. It was made by workgroups from Brazilian Societies of Surgical Oncology, Orthopaedics, Clinical Oncology, Pathology, Radiology and Diagnostic Imaging, and Radiation Oncology. The workgroups based their arguments on the best level of evidence in the literature and recommendations were made according to diagnosis, staging, and treatment of STSs. A meeting was held with all the invited experts and the topics were presented individually with the definition of the degree of recommendation, based on the levels of evidence in the literature.
RESULTS: Risk factors and epidemiology were described as well as the pathological aspects and imaging. All recommendations are described with the degree of recommendation and levels of evidence.
CONCLUSION: Recommendations based on the best literature regional aspects were made to guide professionals who treat STS. Separate consensus on specific treatments for retroperitoneal, visceral, trunk, head and neck sarcomas, and gastrointestinal stromal tumor, are not contemplated into this consensus.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  multidisciplinary sarcoma; sarcoma consensus; sarcoma reference cancer centers; soft tissue sarcomas

Year:  2020        PMID: 31970785     DOI: 10.1002/jso.25847

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Combination of ifosfamide and etoposide as a salvage regimen for previously treated soft tissue sarcomas: a retrospective single centre study.

Authors:  Luiz Fernando Ribeiro; Fernando Augusto Batista Campos; Celso Abdon Mello
Journal:  Ecancermedicalscience       Date:  2022-03-03

2.  Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours.

Authors:  Martin Thaler; Ismail Khosravi; Andreas Leithner; Panayiotis J Papagelopoulos; Pietro Ruggieri
Journal:  Int Orthop       Date:  2020-05-26       Impact factor: 3.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.